A rat cell line derived from DMBA-induced mammary carcinoma

Life Sciences

Volumn 73, Issue 1, 2003, Pages 27-40

  Chow, Louis W C ^a   Cheung, Mary N B ^a   Loo, Wings T Y ^a   Guan, X Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

DMBA; Electron microscopy; Karyotyping; Oestrogen; SD rat

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR ANTIGEN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BODY WEIGHT; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER TRANSPLANTATION; CARCINOGENICITY; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; KARYOTYPE; MITOCHONDRION; MOUSE; NONHUMAN; NUDE MOUSE; TRANSMISSION ELECTRON MICROSCOPY; XENOGRAFT;

MINK CELL FOCUS-FORMING VIRUS; MUS MUSCULUS;

EID: 0037462169     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00253-4     Document Type: Article

References (44)

1. Singletary K., MacDonald C., Wallig M. The plasticizer benzyl butyl phthalate (BBP) inhibits 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary DNA adduct formation and tumorigenesis. Carcinogenesis. 18(8):1997;1669-1673.
2. Miyata M., Furukawa M., Takahashi K., Gonzalez F.J., Yamazoe Y. Mechanism of 7,12-dimethylbenz[a]anthracene-induced immunotoxicity: role of metabolic activation at the target organ. Jpn J Pharmacol. 86(3):2001;302-309.
3. Huggins C., Grand L.D., Brillantes F.P. Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature (Lond.). 189:1961;204-207.
4. Huggins C. Two principles in endocrine therapy of cancers: hormone deprival and hormone interference. Cancer Res. 25:1965;1163-1167.
5. Rigden M.C., Brigham D.W., Helson J.S., Hershey F.B. Histogenesis of breast cancer. Surg. Forum. 15:1964;356-357.
6. Middleton P.F. The histogenesis of mammary tumours induced in the rat by chemical carcinogens. Br. J. Cancer. 19:1965;830-839.
7. Haslam S.Z. Age as a modifying factor of 7,12-fimrthylbenzanthracene-induced mammary carcinogenesis in the Lewis rat. Int. J. Cancer. 23:1979;374-379.
8. Haslam S.Z. The effect of age on the histopathogenesis of 7,12-dimethylbenzanthracene-induced mammary tumours in the Lewis rat. Int. J. Cancer. 26:1980;349-356.
9. Haslam S.Z., Ber H.A. Histopathogenesis of 7,12-dimethylbenzanthracene-induced mammary tumours. Proc. Natl. Acad. Sci. USA. 74:1977;4020-4027.
10. Sinha D., Dao T.L. A direct mechanism of mammary carcinogenesis induced by 7,12-dimethylbenzanthracene. J. Natl. Cancer Inst. 53:1974;841-846.
11. Torgersen O. Regional distribution of DMBA-induced mammary tumours in the rat. Acta Pathol. Microgiol. Scand. 83:1975;639-644.
12. Wang C.S., Goulet F., Lavoie J., Drouin R., Auger F., Champetier S., Germain L., Têtu B. Establishment and characterization of a new cell line derived from a human primary breast carcinoma. Cancer Genet Cytogenet. 120:2000;58-72.
13. Macejova D., Brtko J. Chemically induced carcinogenesis: a comparison of 1-methyl-1-nitrosourea, 7,12-dimethylbenzanthracene, diethylnitroso-amine and azoxymethan models (minireview). Endocr Regul. 35(1):2001;53-59.
14. Kataoka A., Kojiro M., Yakushiji M., Kato T. Establishment and morphologic characterization of cell line (DMBA-OC-1) from 7,12-dimethylbenz[a]anthracene-induced rat ovarian carcinoma. Acta Obst Hynaec Jpn. 39:1987;842-848.
15. Sjoling A., Lindholm H., Samuelson E., Yamasaki Y., Watanabe T.K., Tanigami A., Levan G. Analysis of chromosomal aberrations involving chromosome 1q31→q53 in a DMBA-induced rat fibrosarcoma cell line: amplification and overexpression of Jak2. Cytogenet Cell Genet. 95(3-4):2001;202-209.
16. Clifford W.W. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res. 45:1985;3415-3443.
17. Helou K., Walentinsson A., Kost-Almova M., Levan G. Hgfr/Met oncogene acts as target for gene amplification in DMBA-induced rat sarcomas: free chromatin fluorescence in situ hybridization analysis of amplcon arrays in homogeneously staining regions. Genes, Chromosomes & Cancer. 30:2001;416-420.
18. Cohen L.A., Choi K., Numoto S., Reddy M., Berke B., Weisburger J.H. Inhibition of chemically induced mammary carcinogenesis in rats by long-term exposure to butylated hydroxytoluene (BHT): interrelations among BHT concentration, carcinogen dose, and diet. J Natl Cancer Inst. 76(4):1986;721-730.
19. Freshney R.I. Culture of animal cells: A manual of basic techniques. 3rd ed. 1994;12 Wiley-Liss Inc, New York.
20. Siwek B., Larsimont D., Lacroix M., Body J.J. Establishment and characterization of three new breast-cancer cell lines. Int J Cancer. 76(5):1998;677-683.
21. Watanabe M., Tanaka H., Kamada M., Okano J.H., Takahashi H., Uchida K., Iwamura A., Zeniya M., Ohno T. Establishment of the human BSMZ breast cancer cell line which overexpresses the erbB-2 and c-myc genes. Cancer Res. 52(19):1992;5178-5182.
22. Georg J.K. The handbook of experimental animals: The laboratory rat. 2000;300-301 Academic Press, UK. Chapter 15.
23. Fuchs E.W.K. Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem. 63:1994;345-382.
24. Sundström B.E., Stigbrand T.I. Cytokeratins and tissue polypeptide antigen. Int J Biol Sci. 9(2):1994;102-108.
25. Porowska H., Paszkiewicz-Gadek A., Wolczynski S., Gindzieski A. MUC1 expression in human breast cancer cells is altered by the factors affecting cell proliferation. Neoplasma. 49(2):2002;104-109.
26. Auger M., Hanna W., Kahn H.J. Cystosarcoma phylloides of the breast and its mimics. Arch Pathlo Lab Med. 113:1989;1231-1235.
27. Debus E., Weber K., Osborn M. Monoclonal antibodies to desmin, the muscle specific intermediate filament protein. Embo J. 2:1983;2305-2312.
28. Ogawa K., Nakashima Y., Yamabe H., Hamashima Y. Clear cell sarcoma of the kidney An immunohistochemical study. Acta Pathologica Japonica. 36(5):1986;681-689. [23].
29. Peter M.G., Davenport A.P. Delineation of endothelin receptors in human left ventricular smooth-muscle cells. J Cardiovasc Pharm. 26(3):1995;S355-S357.
30. Ozaki I., Yamamoto K., Mizuta T., Kajihara S., Fukushima N., Setoguchi Y., Morito F., Sakai T. Differential expression of laminin receptors in human hepatocellular carcinoma. Gut. 43:1998;837-842.
31. Walsh M.D. Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro. Breast Cancer Res Treat. 58:1999;255-266.
32. Hardwick M. Peripheral-type benzodiazepine receptor levels correlate with the ability of human breast cancer MDA-MB-231 cell line to grow in SCID mice. Int J Cancer. 94:2001;322-327.
33. Maemura M. Expression and ligand binding of alpha 2 beta 1 integrin on breast carcinoma cells. Clin Exp Metastasis. 13:1995;223-235.
34. Cao S., Hudnall S.D. Measurement of estrogen receptors in intact cells by flow cytometry. Cytometry. 4:2000;109-114.
35. Pieper F.R. Regulation of vimentin expression in cultured epithelial cells. Eur J Biochem. 210:1992;509-519.
36. Elashry-Stowers D. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies. Cancer Res. 48:1988;6462-6474.
37. Parikh I. Are estrogen receptors cytoplasmic or nuclear? Some immunocytochemical and biochemical studies. J Steroid Biochem. 27:1987;185-192.
38. Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci. 910:2000;121-137. [discussion 137-9].
39. Tokino T. Tumor suppressor gene p53. Nippon Rinsho. 54(4):1996;960-964.
40. Lichtenbeld H.C., Barendsz-Janson A.F., van Essen H., Struijker Boudier H., Griffioen A.W., Hillen H.F. Angiogenic potential of malignant and non-malignant human breast tissues in an in vivo angiogenesis model. Int J Cancer. 77(3):1998;455-459.
41. Callagy G., Dimitriadis E., Harmey J., Bouchier-Hayes D., Leader M., Kay E. Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor. Appl Immunohistochem Mol Morphol. 8(2):1999;104-109.
42. Neubauer K., Knittel T., Aurish S., Fellmer P., Ramadori G. Glial fibrillary acidic protein - a cell type specific marker for Ito cells in vivo and in vitro. J Hepathol. 24(6):1996;719-730.
43. Lae M.E., Roche P.C., Jin L., Lloyd R.V., Nascimento A.G. Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical, and molecular study of 32 tumors. The Am J Surg Pathol. 26(7):2002;823-835.
44. Cotran R., Kumar V., Collins T. Robbins pathologic basis of disease. 6th ed. 2000;260. Chapter 8.